Eighteen months into the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2)(coronavirus disease 2019 [COVID-19]) pandemic, epidemiologic studies indicate that …

Introduction Despite a growing body of scholarly research on the risks of severe COVID-19
associated with diabetes, hypertension and obesity, there is a need for estimating pooled …

Background Diabetes is an independent predictor of poor outcomes in patients with COVID-
19. We compared the effects of the preadmission use of antidiabetic medications on the in …

As a first-line treatment for diabetes, the insulin-sensitizing biguanide, metformin, regulates
glucose levels and positively affects cardiovascular function in patients with diabetes and …

Metformin is the most often prescribed drug for people with type 2 diabetes (T2D). More than
120 million patients with T2D use metformin worldwide. However, monotherapy fails to …

Aims We conducted a systematic review and meta-analysis to assess various antidiabetic
agents' association with mortality in patients with type 2 diabetes (T2DM) who have …

Aims/hypothesis To provide a systematic overview of the current body of evidence on high-
risk phenotypes of diabetes associated with COVID-19 severity and death. Methods This is …

Background Whether treatment during acute COVID results in protective efficacy against
long COVID incidence remains unclear. Objectives To assess the relationship between …

The multifaceted interaction between coronavirus disease 2019 (COVID-19) and the
endocrine system has been a major area of scientific research over the past two years …

Hypertension and diabetes mellitus (DM) are two of the leading lifestyle diseases in the
Indian and South Asian populations that often co-exist due to overlap** …